Abbott Laboratories' scientists honored for work on Kaletra
BY Advocate.com Editors
August 27 2003 11:00 PM ET
Three chemists from Abbott Laboratories have been named 2003 Heroes of Chemistry by the American Chemical Society for their work in discovering and developing the HIV protease inhibitor Kaletra. The Heroes of Chemistry program was started in 1996 to honor industrial chemists and chemical engineers who create commercially successful products based on chemistry that improve quality of life. Abbott employees Dale J. Kempf, Daniel W. Norbeck, and Hing L. Sham will be honored at the ACS 226th national meeting in New York City on September 7.
This year's Heroes of Chemistry program salutes those whose work has improved the health and well-being of children. Kempf, Norbeck, and Sham were chosen because Kaletra is used worldwide in treating HIV-positive children and adults. The drug also is the most-prescribed protease inhibitor in the United States. Kaletra, which received simultaneous adult and pediatric approvals from the Food and Drug Administration, is the first HIV protease inhibitor to receive approval for use in children as young as 6 months of age.
- Buck Angel Shuts Down Transgender Surgery Fundraising Site
- Op-ed: Two and a Half Men Introduces Trans Character, Manages to Stay Respectful
- The Many Faces of LGBT Family
- Salvation Army 'Does Not Consider Homosexual Orientation a Sin'
- Marriage Equality Good for New Mexico Kids, Experts Say
- The Financial Effects of DOMA: Newlywed Financial Decisions
- Latest News India Reinstates Gay Sex Ban 48 min 12 sec ago
- Entertainment News Carmen Carrera & Her Victoria's Secret Dream 51 min 31 sec ago
- Media Edie Windsor is No. 3 on Time's Person of Year Shortlist 2 hours 11 min ago
- Commentary Op-ed: Immigration Goes Beyond Documentation 7:00 AM
- Day in LGBT America PHOTOS: The Many Faces of LGBT Family 6:00 AM
- Comedy Meet the Lesbian Who Won a Comedy Cage Match 6:00 AM
- Transgender Buck Angel Shuts Down Transgender Surgery Fundraising Site December 10 2013 9:08 PM